From five hospital visits a month to 217: Butler sends online peptide prescribing to a parliamentary inquiry
Health Minister Mark Butler has asked federal parliament's health committee to investigate how unapproved peptides are prescribed through telehealth, sold through one-stop online dispensaries and pushed on social media. Hearings are due to start this month, with a final report in mid-2027.
Three things to know
- Butler wrote to the House of Representatives Standing Committee on Health chair, Dr Mike Freelander, on Friday asking for the inquiry.
- NSW Health figures show monthly hospital visits linked to peptides rose from five in July 2025 to 217 in September 2026.
- Some peptides are approved medicines, including semaglutides such as Ozempic and Wegovy. The inquiry targets the unapproved products being prescribed and sold online.
The federal government has ordered a parliamentary inquiry into the booming online trade in unapproved peptides, after a sharp rise in hospital visits and poisoning calls linked to the injectable products.
Health Minister Mark Butler wrote on Friday to Dr Mike Freelander, who chairs the House of Representatives Standing Committee on Health, asking it to examine the safety and quality of online peptide prescribing. The request was made public on Sunday. Consultation hearings are expected to begin in November, and the committee is due to deliver its final report in mid-2027.
Butler said the products are marketed online as wonder drugs, but “can pose serious health risks to Australian consumers”.
What will the inquiry look at?
The committee has been asked to examine how common peptide prescribing has become, the benefits and risks of online and direct-to-consumer models of care, and the role that digital platforms and social media play in promoting peptide use.
Butler said he was extremely concerned by escalating reports from the Therapeutic Goods Administration (TGA) about unapproved peptides being prescribed through telehealth services and supplied by one-stop-shop dispensaries.
The TGA has reported a stark rise in the importation, supply, compounding and advertising of unapproved peptides through social media and telehealth.
How big is the problem?
The numbers have climbed fast. NSW Health figures show peptide-linked hospital visits in that state went from five a month in July 2025 to 217 in September 2026: more than seven a day.
The Australian Poisons Information Centre recorded 345 cases involving unapproved peptides in the first six months of 2026, more than three times the total for the whole of 2025.
In September the TGA said a person who had used unapproved peptides came close to dying from a potentially fatal tear in the oesophagus after uncontrollable vomiting.
Who is being targeted by the marketing?
The government’s Special Envoy for Men’s Health, Dan Repacholi, said he was particularly concerned about “young blokes” turning to unapproved products.
“Just because someone with a sixpack is promoting something online doesn’t mean it’s safe,” he said.
Sport Minister Anika Wells said peptides were an emerging risk for athletes, both to the integrity of sport and to their health.
Are all peptides unsafe?
No. Peptides are short chains of amino acids, and some are approved, prescription medicines. Semaglutides such as Ozempic and Wegovy, used for diabetes and weight loss, are peptide medicines approved in Australia.
The concern is the trade in products that have not been approved by the TGA, which are promoted for muscle growth, recovery, weight loss or anti-ageing and are often bought online with little or no medical oversight. The TGA has warned Australians against buying unapproved peptide products online, particularly from overseas websites or through social media.
Why does telehealth matter here?
Telehealth became a mainstream part of Australian medicine during the pandemic, and most of it is ordinary care. But the inquiry has been asked to look at business models where an online consultation and a dispensary sit under one roof, and a prescription can arrive with the product.
Independent MP Dr Monique Ryan, a medical doctor, has separately urged Butler to crack down on rogue telehealth clinics, saying GPs have raised concerns about telehealth prescribing of peptides and other drugs.
For readers, the practical message from regulators is unchanged: if a peptide is sold without a proper consultation with a doctor who knows your history, or is promoted by an influencer as a quick fix, treat it as a risk to your health.
What happens to the industry in the meantime?
Nothing changes in law until the committee reports and the government responds. The TGA can still act against unlawful advertising and supply under existing rules, and has been issuing warnings through 2026.
The Coalition has not yet said whether it supports the inquiry.
If you are worried about a product you have used, talk to your doctor, or call the Poisons Information Centre on 13 11 26.
How we got here
The key moments that brought this story into focus. Open any moment for detail.
2025Peptide visits begin to climb
NSW Health records five peptide-linked hospital visits in July 2025.
September 2026Near-fatal case
The TGA reports a user of unapproved peptides nearly died from an oesophageal tear; NSW peptide-linked hospital visits reach 217 for the month.
First half of 2026Poisoning calls triple
The Australian Poisons Information Centre records 345 cases involving unapproved peptides.
20 November 2026Inquiry requested
Mark Butler writes to health committee chair Mike Freelander.
22 November 2026Inquiry made public
The government announces the inquiry, with hearings from November.
What happens next
The Standing Committee on Health is expected to call for submissions and begin consultation hearings in November, and to deliver its final report in mid-2027. The government will then decide whether to tighten rules on telehealth prescribing, online dispensaries and peptide advertising.
Sources
- VNN
VNN never names people who give us information in confidence. How we protect sources and tips.
That is the story in a minute. For the evidence, context and what happens next, switch to the full story.
Weather today
Sunday 22 November
Perth
Mild with rain nearby · 18% rain
20°15°
Sydney heats to 30 and Melbourne 28 while Perth stays mild; rain soaks Paris and New York, and storms build over Sao Paulo.
- Sydney30°19°
- Melbourne28°15°
- Brisbane26°18°
- Adelaide26°17°
- Auckland19°13°
- Singapore30°25°
More cities (13)
- Tokyo13°6°
- Hong Kong21°17°
- Mumbai30°21°
- Dubai31°20°
- Nairobi23°16°
- Lagos30°26°
- Johannesburg28°18°
- London8°5°
- Paris8°7°
- New York14°10°
- Los Angeles18°11°
- Toronto13°5°
- Sao Paulo32°22°
Highs and lows in °C, local time.
Breaking now
Live deskDeveloping stories
Live deskStories we’re following
Live deskMost read this week
For subscribers
Read every subscriber story in full, on any device. Premium reports are sold separately.
Secure payment · Cancel anytime · Subscribers sign in
Markets
Stocks
- Alphabet (GOOGL)Nasdaq265.29 USDdown -2.70%
- Amazon (AMZN)Nasdaq246.82 USDdown -4.10%
- Apple (AAPL)Nasdaq342.56 USDdown -1.90%
- ASX 200ASX8,730down -1.04%
- Berkshire Hathaway (BRK.B)NYSE570.00 USDdown -0.36%
- BHP Group (BHP)ASX51.40 AUDdown -1.80%
Currencies
- AUD/EURForex0.607100 EURdown -0.31%
- AUD/GBPForex0.508500 GBPup +0.02%
- AUD/JPYForex106.1100 JPYdown -0.41%
- AUD/NZDForex1.212700 NZDdown -0.18%
- AUD/USDForex0.666600 USDdown -0.16%
- BTC/USDCrypto58,970.00 USDdown -5.21%
As at 21 Nov 2026, 6:40 am GMT+0800. Entered by VNN. Not financial advice.
For you
Follow the topics you care about and save stories with the bookmark. They gather here, on this device only.
Saved on this device only. Nothing is sent to VNN.
Help keep the lights on.
Independent news costs money to make and nothing to read. Chip in and keep it that way.
ContributeFrom A$5 a month · Cancel anytimeThe daily briefing
Start informed.
The essential headlines, the useful context and what to watch next, in your inbox each morning.







Comments
0 commentsCommunity rules
To read and join the conversation, please agree to our rules.
You have agreed to the community rules.
No comments yet. Start the conversation.